drug · small molecule
trametinib dimethyl sulfoxide
Phase 2updated 2mo agoby $NVS NOVARTIS AG🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 6Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 3 investigational indications.
targets
Dual specificity mitogen-activated protein kinase kinase 2Dual specificity mitogen-activated protein kinase kinase 1
all catalysts(0)
nothing on the calendar yet
Trials studying trametinib dimethyl sulfoxide
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 25m ago
Found something off?
comments(0)
5-min edit window · permanent after that